MAPK8 and osteoporosis: In line with the above results, puerarin combined with SP600125 suppressed DEX-apoptosis to a lesser extent, compared with SP600125 alone, suggesting that puerarin enhanced the anti-apoptotic effect of the JNK inhibitor, and that combination treatment may be a potentially therapeutic option for GC-induced osteoporosis.